JP2009523007A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009523007A5 JP2009523007A5 JP2007536171A JP2007536171A JP2009523007A5 JP 2009523007 A5 JP2009523007 A5 JP 2009523007A5 JP 2007536171 A JP2007536171 A JP 2007536171A JP 2007536171 A JP2007536171 A JP 2007536171A JP 2009523007 A5 JP2009523007 A5 JP 2009523007A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- replaced
- adenovirus
- batch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61846904P | 2004-10-13 | 2004-10-13 | |
| EP04105005 | 2004-10-13 | ||
| US60/618,469 | 2004-10-13 | ||
| EP04105005.5 | 2004-10-13 | ||
| US69772405P | 2005-07-08 | 2005-07-08 | |
| US60/697,724 | 2005-07-08 | ||
| PCT/EP2005/055183 WO2006040330A2 (en) | 2004-10-13 | 2005-10-12 | Improved adenoviral vectors and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009523007A JP2009523007A (ja) | 2009-06-18 |
| JP2009523007A5 true JP2009523007A5 (https=) | 2010-10-28 |
| JP4843613B2 JP4843613B2 (ja) | 2011-12-21 |
Family
ID=34929696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007536171A Expired - Fee Related JP4843613B2 (ja) | 2004-10-13 | 2005-10-12 | 改良されたアデノウイルスベクターおよびその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JP4843613B2 (https=) |
| CN (1) | CN101072879B (https=) |
| AT (1) | ATE492643T1 (https=) |
| DE (1) | DE602005025512D1 (https=) |
| ES (1) | ES2358523T3 (https=) |
| ZA (1) | ZA200702792B (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2391638T3 (pl) * | 2009-02-02 | 2018-11-30 | Glaxosmithkline Biologicals Sa | Sekwencje nukleotydowe i aminokwasowe małpiego adenowirusa, zawierające je wektory i ich zastosowania |
| WO2011022002A1 (en) * | 2009-08-18 | 2011-02-24 | The Rockefeller University | Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes |
| EP2558481B1 (en) * | 2010-04-14 | 2017-12-20 | Mogam Biotechnology Research Institute | Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the same |
| DK2655604T3 (en) * | 2010-12-14 | 2018-08-06 | Us Gov Health & Human Services | ADENOVIRUS SEROTYPE-26- AND SEROTYPE-35-FILOVIRUS VACCINES |
| CN102199616B (zh) * | 2011-03-07 | 2013-04-24 | 首都医科大学附属北京佑安医院 | Hiv-1表型耐药检测载体及其构建方法 |
| JP6757120B2 (ja) * | 2011-10-05 | 2020-09-16 | ジェンヴェック エルエルシー | アーフェンアデノウイルス（ゴリラ）又はアデノウイルスベクター、及び使用方法 |
| JP5805908B2 (ja) * | 2012-03-22 | 2015-11-10 | クルセル ホランド ベー ヴェー | Ｒｓｖに対するワクチン |
| IL315940A (en) | 2015-07-28 | 2024-11-01 | Univ Pennsylvania | Altered monocytes/macrophages expressing chimeric antigen receptors and their uses |
| EP3532082A4 (en) * | 2016-12-12 | 2020-08-26 | Salk Institute for Biological Studies | SYNTHETIC ADENOVIRUS TUMOR TARGETING AND THEIR USES |
| CN106868047B (zh) * | 2017-03-07 | 2020-04-28 | 南方医科大学 | 一种重组腺病毒载体及其构建方法和用途 |
| ES2906441T3 (es) * | 2017-07-05 | 2022-04-18 | Nouscom Ag | Secuencias de ácidos nucleicos y de aminoácidos del adenovirus de los grandes simios no humanos, vectores que las contienen y usos de las mismas |
| CN107267469B (zh) * | 2017-08-22 | 2020-06-16 | 广州医科大学附属第一医院 | 纤毛蛋白嵌合型重组人b型腺病毒及其制备方法 |
| CN111372943B (zh) * | 2017-10-31 | 2023-12-05 | 扬森疫苗与预防公司 | 腺病毒及其用途 |
| WO2019086461A1 (en) * | 2017-10-31 | 2019-05-09 | Janssen Vaccines & Prevention B.V. | Adenovirus vectors and uses thereof |
| EP3774852A1 (en) | 2018-04-03 | 2021-02-17 | Stridebio, Inc. | Antibody-evading virus vectors |
| EP4079750A3 (en) * | 2018-11-21 | 2023-01-04 | Mayo Foundation for Medical Education and Research | Adenoviruses and methods for using adenoviruses |
| EP3927833A4 (en) * | 2019-02-21 | 2022-11-30 | Unleash Immuno Oncolytics, Inc. | ONCOLYTIC ADENOVIRAL VECTOR AND METHODS OF USE |
| EP4161536A4 (en) | 2020-06-04 | 2024-08-14 | Carisma Therapeutics Inc. | Novel constructs for chimeric antigen receptors |
| CN114262692A (zh) * | 2021-11-30 | 2022-04-01 | 华中科技大学同济医学院附属同济医院 | 一种携带tmvp1和hsv-tk的溶瘤腺病毒重组体，其构建方法及应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6127525A (en) * | 1995-02-21 | 2000-10-03 | Cornell Research Foundation, Inc. | Chimeric adenoviral coat protein and methods of using same |
| US5922315A (en) * | 1997-01-24 | 1999-07-13 | Genetic Therapy, Inc. | Adenoviruses having altered hexon proteins |
| EP1409748B1 (en) * | 2001-06-22 | 2011-10-26 | The Trustees of The University of Pennsylvania | Recombinant Adenoviruses comprising simian adenovirus proteins and uses thereof. |
-
2005
- 2005-10-12 DE DE602005025512T patent/DE602005025512D1/de not_active Expired - Lifetime
- 2005-10-12 AT AT05815456T patent/ATE492643T1/de active
- 2005-10-12 CN CN2005800351365A patent/CN101072879B/zh not_active Expired - Fee Related
- 2005-10-12 JP JP2007536171A patent/JP4843613B2/ja not_active Expired - Fee Related
- 2005-10-12 ES ES05815456T patent/ES2358523T3/es not_active Expired - Lifetime
-
2007
- 2007-04-03 ZA ZA200702792A patent/ZA200702792B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009523007A5 (https=) | ||
| Akusjarvi | Temporal regulation of adenovirus major late alternative RNA splicing | |
| Havenga et al. | Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER. C6 cells | |
| Vogels et al. | Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity | |
| Lasaro et al. | New insights on adenovirus as vaccine vectors | |
| JP4787936B2 (ja) | 癌処理への使用のためのキメラアデノウィルス | |
| Reddy et al. | Nucleotide sequence, genome organization, and transcription map of bovine adenovirus type 3 | |
| JP5097714B2 (ja) | Ｅ１領域内の発現カセットと不活性化されたｅ２ｂポリメラーゼを有するアデノウイルス発現ベクター | |
| Zhang et al. | Role for the adenovirus IVa2 protein in packaging of viral DNA | |
| JP2015057052A5 (https=) | ||
| JP2020022459A5 (https=) | ||
| Von Seggern et al. | Complementation of a fibre mutant adenovirus by packaging cell lines stably expressing the adenovirus type 5 fibre protein | |
| JP2014516536A5 (https=) | ||
| CN1382218A (zh) | 溶瘤腺病毒 | |
| JP5980117B2 (ja) | サルアデノウイルスベクターの増殖方法 | |
| JP2005505286A5 (https=) | ||
| US6844192B2 (en) | Adenovirus E4 protein variants for virus production | |
| JP2008518591A5 (https=) | ||
| Roy et al. | Complete nucleotide sequences and genome organization of four chimpanzee adenoviruses | |
| Lusky et al. | Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: requirement for E4 ORF3 | |
| Stone et al. | The complete nucleotide sequence, genome organization, and origin of human adenovirus type 11 | |
| JP2008510493A5 (https=) | ||
| CN1655827A (zh) | 腺病毒和编码其的核酸的新应用 | |
| Khatri et al. | Gene Expression by Atypical Recombinant Ovine Adenovirus Vectors during Abortive Infection of Human and Animal Cellsin Vitro | |
| JP2011521661A5 (https=) |